Press coverage about Walgreens Boots Alliance (NASDAQ:WBA) has trended positive on Saturday, Alpha One Sentiment reports. Alpha One, a subsidiary of Accern, identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a media sentiment score of 0.44 on Alpha One’s scale. Alpha One also assigned press coverage about the pharmacy operator an impact score of 0 out of 100, meaning that recent media coverage is extremely unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news stories that may have impacted Alpha One’s rankings:
- RSI Alert: Walgreens Boots Alliance (WBA) Now Oversold (nasdaq.com)
- Walgreens Boots Alliance Inc (WBA) Has Another Very Weak Trading Session (ibusinesslines.com)
- Walgreens Gets Its Geek On With Steve Jackson Games (Again) (finance.yahoo.com)
- Why Whole Foods Market’s Gain Is CVS Health’s and Walgreens’ Loss Today (fool.com)
- Analyzing Walgreens Boots Alliance (WBA) & Rite Aid Corporation (RAD) (americanbankingnews.com)
Walgreens Boots Alliance (NASDAQ WBA) traded down 4.99% during midday trading on Friday, reaching $78.44. The company had a trading volume of 14,953,927 shares. Walgreens Boots Alliance has a 12 month low of $76.26 and a 12 month high of $89.69. The firm’s 50-day moving average price is $83.02 and its 200 day moving average price is $83.80. The firm has a market capitalization of $84.79 billion, a PE ratio of 20.16 and a beta of 1.20. Walgreens Boots Alliance also was the recipient of some unusual options trading on Thursday. Stock investors bought 23,262 call options on the company. This is an increase of approximately 320% compared to the average daily volume of 5,535 call options.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 EPS for the quarter, meeting analysts’ consensus estimates of $1.36. The firm had revenue of $29.45 billion during the quarter, compared to the consensus estimate of $30.17 billion. Walgreens Boots Alliance had a return on equity of 16.86% and a net margin of 3.66%. Walgreens Boots Alliance’s revenue for the quarter was down 2.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.31 earnings per share. Equities analysts anticipate that Walgreens Boots Alliance will post $4.97 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Monday, June 12th. Investors of record on Thursday, May 18th were issued a $0.375 dividend. This represents a $1.50 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date was Tuesday, May 16th. Walgreens Boots Alliance’s dividend payout ratio is currently 38.36%.
A number of research firms recently weighed in on WBA. Barclays PLC set a $79.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Saturday, April 1st. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday. Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Friday, March 31st. Guggenheim restated a “buy” rating and set a $100.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. Finally, Leerink Swann set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Tuesday, April 11th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $90.62.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Following the transaction, the director now owns 21,887 shares of the company’s stock, valued at approximately $1,879,874.43. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2230439/walgreens-boots-alliance-wba-earns-coverage-optimism-rating-of-0-44.html
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.